27 April 1987
INTERIM COMMERCIAL ITEM DESCRIPTION
GLOBULIN, IMMUNE FOR INJECTION, HUMAN, DRIED
The General Services Administration has authorized the use of this Interim Commercial Item Description which was developed by DLA, Defense Personnel Support Center, Directorate of Medical Materiel, DPSC-RST, 2800 South 20th Street, Philadelphia, PA 19101, based upon currently available technical information.
Shall be a sterile, dried Globulin, Immune (Human) for injection (intracvenous).
Materials used in the manufacture of the product shall be of a pharmaceutical grade.
Shall contain 50 mg of protein per ml when reconstituted with the appropriate volume of diluent.
When assayed, at least 90 percent of the protein shall be gamma globulin.
Samples of the final, filled immediate containers shall be submitted as follows:
The quality assurance representative, when inspection is at source, or the contractor, when inspection is at destination, shall send the following by the fastest route directly to:
Department of Biologics Research
Division of Communicable Disease and Immunology
Walter Reed Army Institute of Research, Bldg 40
ATTN: Mr. Calvin Powell, Room 2022
Washington, DC 20307-5100
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business